New and Special Drug
CIMZIA (Certolizumab Pegol) – Rheumatoid Arthritis | HongKong DengYue Medicine
Xeljanz (Tofacitinib) – Rheumatoid Arthritis | HongKong DengYue Medicine
RINVOQ (Upadacitinib) – Active Psoriasis | HongKong DengYue Medicine
Cosentyx (Secukinumab) – Plaque Psoriasis | HongKong DengYue Medicine
OLUMIANT (Baricitinib) – Rheumatoid Arthritis | HongKong DengYue Medicine
CIBINQO (Abrocitinib) – Atopic Dermatitis | HongKong DengYue Medicine
ACTEMRA (Tocilizumab) – Rheumatoid Arthritis | HongKong DengYue Medicine
Lynparza (Olaparib) – Ovarian Cancer | HongKong DengYue Medicine
Lenvima (Lenvatinib) – HCC | HongKong DengYue Medicine
Prezcobix (Darunavir and Cobicistat) – HIV | HongKong DengYue Medicine
Praxbind (Idarucizumab) – Dabigatran Toxicity | HongKong DengYue Medicine
Albuvirtide Injection (Aikening) – HIV | HongKong DengYue Medicine
Deltyba (delamanid) – MDR-TB | HongKong DengYue Medicine
Eylea (aflibercept) – Diabetic Retinopathy | HongKong DengYue Medicine
Daboshu (Sintilimab Injection) – Lung Cancer | HongKong DengYue Medicine
NUZYRA (Omadacycline) – Antibiotics | HongKong DengYue Medicine
